Handelsavisen
prelaunch
Companies Healthcare SAUHY.O
SA
SAUHY.O NASDAQ Health Care Equipment & Supplies

Straumann Holding AG

$12,65
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
20,2B USD
P/E
EV / Rev
Div yield
1,09 %
Op margin
21,1 %
ROE
16,5 %
Net margin
13,7 %
Debt / equity
0,19
Beta
52w range
Volume
Day range
Prev close
$11,76
Open
Next earnings
Ex-dividend
TR 1Y
About

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration, developing implants, instruments, and CAD/CAM prosthetics for tooth replacement and restoration solutions.

Business. Straumann Holding AG (SAUHY.O) is a health care equipment and supplies company that develops, manufactures, and markets dental implants and related products. The firm operates within the Health Care sector, focusing on the production of medical devices for dental procedures. Straumann is headquartered in Switzerland and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments or geographic revenue mix are not provided in the available data.

Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
PNC Investments LLC
largest disclosed fund holder
Profitability
16,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SAUHY.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SAUHY.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Straumann Holding AG (SAUHY.O) is a health care equipment and supplies company that develops, manufactures, and markets dental implants and related products. The firm operates within the Health Care sector, focusing on the production of medical devices for dental procedures. Straumann is headquartered in Switzerland and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments or geographic revenue mix are not provided in the available data.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Equipment & Supplies
    AI synthesis
    GENERATED

    Straumann Holding AG maintains a conservative capital structure with a debt-to-equity ratio of 0.19 and a current ratio of 2.21, indicating strong short-term liquidity coverage. The balance sheet shows total assets of CHF 3.76 billion against total liabilities of CHF 1.60 billion, resulting in total equity of CHF 2.16 billion. However, the company holds only CHF 14.0 million in cash and equivalents against long-term debt of CHF 418.9 million, resulting in a net cash position that is negative after subtracting total debt. This structural deficit in liquid reserves relative to debt obligations contributes to a medium liquidity risk rating.

    Profitability metrics demonstrate strong returns on capital, with a return on equity of 16.47% and a return on assets of 9.47%. The company generated operating income of CHF 549.2 million on revenue of CHF 2.61 billion, yielding an operating margin of approximately 21.1%. Net income stood at CHF 355.9 million, reflecting a net margin of roughly 13.7%. While specific cohort median comparisons are not provided in the input data, these return metrics suggest efficient capital deployment typical of high-margin medical device manufacturers.

    Revenue generation is driven by the company's core activities in implant and restorative dentistry and oral tissue regeneration. The business model relies on collaboration with clinics, research institutes, and universities to develop and sell implants, instruments, and computer-aided design/manufacturing (CAD/CAM) prosthetics. The company also provides training and education services to the dental profession worldwide. Specific segment or geographic revenue breakdowns are not available in the provided data, preventing a detailed analysis of concentration risk by region or product line.

    Growth trajectory analysis is limited by the absence of historical period data in the input. The latest normalized period shows revenue of CHF 2.61 billion and free cash flow of CHF 141.4 million. Capital expenditure was significant at CHF 223.5 million, which reduced free cash flow relative to operating cash flow of CHF 504.0 million. Without multi-year historical data, year-over-year growth rates and trend consistency cannot be calculated.

    Risk assessment highlights medium liquidity risk and low dilution risk. A key flag notes that net cash is negative after subtracting total debt, which may constrain financial flexibility despite the low leverage ratio. The company has 11,821 employees and a total share float of 113.5 million shares. ESG pillar scores indicate high controversy scores (100/100) alongside governance (69/100) and social (78/100) scores, suggesting potential reputational or operational risks that may impact stakeholder perception.

    Recent observations include a failed analysis re-drive event recorded in the system logs, which is an internal processing artifact and not a business event. The company is headquartered in Switzerland and was incorporated in 2005. No specific recent filings, news events, or transcript observations regarding business operations, mergers, or strategic shifts are present in the input data.

    Key takeaways
    • Straumann generates strong returns with 16.47% ROE and 9.47% ROA, supported by a 21.1% operating margin.
    • The company carries a negative net cash position due to CHF 418.9 million in long-term debt against only CHF 14.0 million in cash.
    • Liquidity risk is rated medium, primarily driven by the net cash deficit despite a healthy 2.21 current ratio.
    • Dilution risk is low, with basic and diluted shares outstanding being identical at 1.59 billion shares.
    • High ESG controversy scores (100/100) may present reputational risks despite strong governance and social scores.
    • Valuation multiples are elevated, with a P/E of 52.68 and EV/EBITDA of 34.88, reflecting premium pricing for the business.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $12,65
    Market cap
    $18.75B
    Enterprise value
    $19.16B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    38.0x
    P / B
    8.7x
    P / Tangible book
    8.7x
    Tangible book
    $2.16B
    Net cash
    -$404.9M
    Current ratio
    2.2
    Debt / equity
    0.2
    ROA
    9.5%
    ROE
    16.5%
    Cash conversion
    142.0%
    CapEx / revenue
    -8.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    12-month price target$15,00 · Median $15,00
    Low $15,00High $15,00
    Operating income · consensus888,7M CHF
    EPS surprise
    −12,4 %
    reported vs consensus · miss
    Revenue surprise
    −9,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin21,1 %Above P75
    Net Margin13,7 %Above P75
    ROE16,5 %Above P75
    Capex / Rev-8,6 %Bottom quartile
    D/E0,19Above median
    Cash Conv1,42Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • Straumann Holding AG Market data — financials · 2026-07-28
    • failed_redrive (failed_redrive) on SAUHY.O · 2026-07-28
    • Straumann Holding AG — company reference export (2026-07-05) · 2026-07-28

    Ownership & reference

    Top holders

    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    23.0Kshares short-51.0% vs prior
    1days to cover
    1.7Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SAUHY.PKCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage